GSK-163090

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-163090
Drug Alias NameGSK-163090163090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor antagonistsSerotonin 1a (5-HT1a) receptor antagonistsSerotonin 1b (5-HT1b) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1a (5-HT1a) receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRussian Federation +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A